FDAFDA recall D-0746-2026 · Aug 19, 2026
Novartis Pharmaceuticals Corporation: Diovan (valsartan) 160 mg recall
Quick answer
- Product
- Diovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834, Distributed by: Novartis Pharmaceutical Corp, East Hanover, NJ 07936, NDC 0078-0359-34
- Brand
- Novartis Pharmaceuticals Corporation
- Codes, lots and dates
- Lot AV5913C, Expiry: 6/2027
- Hazard
- Failed Dissolution Specifications
- Distribution
- US Nationwide
- Recall date
- Aug 19, 2026
- Agency
- U.S. Food and Drug Administration (FDA) enforcement report
- Recall number
- D-0746-2026
Recall found
Product
Diovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834, Distributed by: Novartis Pharmaceutical Corp, East Hanover, NJ 07936, NDC 0078-0359-34
Reason for recall
Failed Dissolution Specifications
What to do
FDA enforcement reports don't include consumer instructions. Check the codes below against your packaging. If this is a medicine or device you use, talk to your pharmacist or doctor before you stop or change anything, and contact the company or FDA for what to do with the product.
| Codes, lots and dates | Lot AV5913C, Expiry: 6/2027 |
|---|---|
| Distribution | US Nationwide |
| Recall date | Aug 19, 2026 |
| Class | Class II |
| Agency ID | D-0746-2026 |
| Official notice | U.S. Food and Drug Administration (FDA) enforcement report |
| Data as of, last checked | Nov 21, 2026, 3:48 PM EST |
Recall details
- FDA classification
- Class II: use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
- Status
- Ongoing
- Codes, lots and dates
- Lot AV5913C, Expiry: 6/2027
- Distribution
- US Nationwide
- Recalling firm
- Novartis Pharmaceuticals Corporation, East Hanover, NJ
- Voluntary or mandated
- Voluntary: Firm initiated
- Recall started
- 2026-08-04
Source: openFDA enforcement record D-0746-2026 · search recall number D-0746-2026 in FDA's Enforcement Report.
Copied from the agency record without changes. Data as of Nov 21, 2026, 3:48 PM EST. The agency notice is the final word.
FAQ
What was recalled?
Product: Diovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834, Distributed by: Novartis Pharmaceutical Corp, East Hanover, NJ 07936, NDC 0078-0359-34 Brand: Novartis Pharmaceuticals Corporation Codes, lots and dates: Lot AV5913C, Expiry: 6/2027
What is the hazard?
Failed Dissolution Specifications
How do I check if mine is affected?
Codes, lots and dates: Lot AV5913C, Expiry: 6/2027
Where was it distributed?
US Nationwide
Related recalls
- Greenwich: Compounded sterile products
- Breckenridge Pharmaceutical, Inc.: Propranolol Hydrochloride Extended-Release Capsules, USP, 60mg
- React Health dba 3B Medical, Inc.: Bilevel Positive Airway Pressure (BPAP) System
- Rocky Mountain Nutrition, LLC: Santa Cruz Paleo Pineapple Caffeine and Island Punch Caffeine Pre-Workout Powder
- bioQuad Life Sciences: OsteoDenx capsules
- Medline: Beds, Rails, Mattresses, and accessories
